BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27794001)

  • 1. IL-18 and Subcapsular Lymph Node Macrophages are Essential for Enhanced B Cell Responses with TLR4 Agonist Adjuvants.
    Desbien AL; Dubois Cauwelaert N; Reed SJ; Bailor HR; Liang H; Carter D; Duthie MS; Fox CB; Reed SG; Orr MT
    J Immunol; 2016 Dec; 197(11):4351-4359. PubMed ID: 27794001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses.
    Seydoux E; Liang H; Dubois Cauwelaert N; Archer M; Rintala ND; Kramer R; Carter D; Fox CB; Orr MT
    J Immunol; 2018 Jul; 201(1):98-112. PubMed ID: 29769270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL-18, and IFN-γ.
    Desbien AL; Reed SJ; Bailor HR; Dubois Cauwelaert N; Laurance JD; Orr MT; Fox CB; Carter D; Reed SG; Duthie MS
    Eur J Immunol; 2015 Feb; 45(2):407-17. PubMed ID: 25367751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for TH1 Induction.
    Dubois Cauwelaert N; Desbien AL; Hudson TE; Pine SO; Reed SG; Coler RN; Orr MT
    PLoS One; 2016; 11(1):e0146372. PubMed ID: 26731269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection.
    Baldwin SL; Hsu FC; Van Hoeven N; Gage E; Granger B; Guderian JA; Larsen SE; Lorenzo EC; Haynes L; Reed SG; Coler RN
    Front Immunol; 2018; 9():295. PubMed ID: 29515589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adjuvant GLA-SE promotes human Tfh cell expansion and emergence of public TCRβ clonotypes.
    Hill DL; Pierson W; Bolland DJ; Mkindi C; Carr EJ; Wang J; Houard S; Wingett SW; Audran R; Wallin EF; Jongo SA; Kamaka K; Zand M; Spertini F; Daubenberger C; Corcoran AE; Linterman MA
    J Exp Med; 2019 Aug; 216(8):1857-1873. PubMed ID: 31175140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and cellular response profiles induced by the TLR4 agonist-based adjuvant Glucopyranosyl Lipid A.
    Lambert SL; Yang CF; Liu Z; Sweetwood R; Zhao J; Cheng L; Jin H; Woo J
    PLoS One; 2012; 7(12):e51618. PubMed ID: 23284726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant.
    Orr MT; Duthie MS; Windish HP; Lucas EA; Guderian JA; Hudson TE; Shaverdian N; O'Donnell J; Desbien AL; Reed SG; Coler RN
    Eur J Immunol; 2013 Sep; 43(9):2398-408. PubMed ID: 23716300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of GLA/SE as an effective adjuvant for the induction of robust humoral and cell-mediated immune responses to EBV-gp350 in mice and rabbits.
    Heeke DS; Lin R; Rao E; Woo JC; McCarthy MP; Marshall JD
    Vaccine; 2016 May; 34(23):2562-9. PubMed ID: 27085175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis.
    Orr MT; Fox CB; Baldwin SL; Sivananthan SJ; Lucas E; Lin S; Phan T; Moon JJ; Vedvick TS; Reed SG; Coler RN
    J Control Release; 2013 Nov; 172(1):190-200. PubMed ID: 23933525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative treatment with the new synthetic TLR-4 agonist GLA-SE reduces cancer metastasis without adverse effects.
    Matzner P; Sorski L; Shaashua L; Elbaz E; Lavon H; Melamed R; Rosenne E; Gotlieb N; Benbenishty A; Reed SG; Ben-Eliyahu S
    Int J Cancer; 2016 Apr; 138(7):1754-64. PubMed ID: 26453448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced humoral and Type 1 cellular immune responses with Fluzone adjuvanted with a synthetic TLR4 agonist formulated in an emulsion.
    Baldwin SL; Shaverdian N; Goto Y; Duthie MS; Raman VS; Evers T; Mompoint F; Vedvick TS; Bertholet S; Coler RN; Reed SG
    Vaccine; 2009 Oct; 27(43):5956-63. PubMed ID: 19679214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD169+ Subcapsular Macrophage Role in Antigen Adjuvant Activity.
    Lisk C; Yuen R; Kuniholm J; Antos D; Reiser ML; Wetzler LM
    Front Immunol; 2021; 12():624197. PubMed ID: 33815376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming the Neonatal Limitations of Inducing Germinal Centers through Liposome-Based Adjuvants Including C-Type Lectin Agonists Trehalose Dibehenate or Curdlan.
    Vono M; Eberhardt CS; Mohr E; Auderset F; Christensen D; Schmolke M; Coler R; Meinke A; Andersen P; Lambert PH; Mastelic-Gavillet B; Siegrist CA
    Front Immunol; 2018; 9():381. PubMed ID: 29541075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in neonates.
    Vono M; Mastelic-Gavillet B; Mohr E; Östensson M; Persson J; Olafsdottir TA; Lemeille S; Pejoski D; Hartley O; Christensen D; Andersen P; Didierlaurent AM; Harandi AM; Lambert PH; Siegrist CA
    Front Immunol; 2023; 14():1155200. PubMed ID: 37063899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.
    Lambert SL; Aslam S; Stillman E; MacPhail M; Nelson C; Ro B; Sweetwood R; Lei YM; Woo JC; Tang RS
    PLoS One; 2015; 10(3):e0119509. PubMed ID: 25793508
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Zhang W; Ahmad G; Molehin AJ; Torben W; Le L; Kim E; Lazarus S; Siddiqui AJ; Carter D; Siddiqui AA
    J Investig Med; 2018 Dec; 66(8):1124-1132. PubMed ID: 29997146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivo.
    Pantel A; Cheong C; Dandamudi D; Shrestha E; Mehandru S; Brane L; Ruane D; Teixeira A; Bozzacco L; Steinman RM; Longhi MP
    Eur J Immunol; 2012 Jan; 42(1):101-9. PubMed ID: 22002164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of GLA family adjuvants' activities.
    Reed SG; Carter D; Casper C; Duthie MS; Fox CB
    Semin Immunol; 2018 Oct; 39():22-29. PubMed ID: 30366662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced immunogenicity of a respiratory syncytial virus (RSV) F subunit vaccine formulated with the adjuvant GLA-SE in cynomolgus macaques.
    Patton K; Aslam S; Shambaugh C; Lin R; Heeke D; Frantz C; Zuo F; Esser MT; Paliard X; Lambert SL
    Vaccine; 2015 Aug; 33(36):4472-8. PubMed ID: 26206269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.